LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Strona główna・Stock List・NeoGenomics Inc

NeoGenomics Inc

Closed

8.23 -1.08

Buy Sell

Overview

Share price change

24h

Current

Min

8.19

Max

8.4

Key metrics
By Trading Economics
Income	-7.2M -17M
Sales	-3.5M 187M
EPS	0.01
Profit margin	-9.164
Employees	2,500
EBITDA	-5.8M -567K

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+80.87% upside

Dividends
By Dow Jones
Next Earnings	28 lip 2026

Market Stats
By TradingEconomics
Market Cap	7.1M 1.1B
Previous open	9.31
Previous close	8.23

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

7.7 / 10.27 Support & Resistance

NeoGenomics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 maj 2026, 14:22 UTC

Major Market Movers

Coincheck Shares Rise on $65 Million KDDI Investment, Digital-Asset Alliance

14 maj 2026, 23:57 UTC

Acquisitions, Mergers, Takeovers

Kakao: Stake Sales Aim to Secure Funds for Future Investments

14 maj 2026, 23:56 UTC

Acquisitions, Mergers, Takeovers

Kakao: Share Sale to Lower Kakao Investment's Stake in Dunmau to 4.03%

14 maj 2026, 23:56 UTC

Acquisitions, Mergers, Takeovers

Kakao: Affiliate Kakao Investment to Sell 2.3M Dunamu Shares on June 15

14 maj 2026, 23:56 UTC

Acquisitions, Mergers, Takeovers

Kakao to Sell 6.55% Stake in Crypto Exchange Operator Dunamu to Hana Financial for KRW1.003T

14 maj 2026, 17:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 maj 2026, 17:13 UTC

Market Talk

Higher Interest Rates for Longer Seen Positive for Stablecoins -- Market Talk

14 maj 2026, 14:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 maj 2026, 14:43 UTC

Market Talk

Bitcoin Stabilizes After $630M ETF Outflow -- Market Talk

14 maj 2026, 11:48 UTC

Market Talk

Bitcoin Turns Slightly Lower Amid Inflation Concerns, Iran War -- Market Talk

14 maj 2026, 07:25 UTC

Market Talk

Bitcoin Edges Higher But Recovery Limited -- Market Talk

13 maj 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

13 maj 2026, 16:58 UTC

Market Talk

Change to Ethereum Staking Could Boost Prices, Says Grayscale -- Market Talk

13 maj 2026, 16:53 UTC

Market Talk

Bitcoin Retreats to Short-Term Resistance Levels -- Market Talk

13 maj 2026, 15:37 UTC

Market Talk

Bitcoin Moves Back Under $80K as Crypto Caution Remains -- Market Talk

13 maj 2026, 12:51 UTC

Market Talk

Bitcoin Turns Lower as Trump-Xi Meeting Eyed -- Market Talk

13 maj 2026, 07:44 UTC

Market Talk

Bitcoin Rises But Middle East Tensions Limit Gains -- Market Talk

13 maj 2026, 07:44 UTC

Market Talk

Global Energy Roundup: Market Talk

12 maj 2026, 20:35 UTC

Earnings

Fold Holdings: 1Q Total Verified Accounts Nearly 85,000, Added Close to 2,000 New Verified Accounts >FLD

12 maj 2026, 20:35 UTC

Earnings

Fold Holdings: 1Q Total Transaction Volume: $172M; 32% YoY Decrease >FLD

12 maj 2026, 20:34 UTC

Earnings

Fold Holdings: More Than 1,000 Fold Bitcoin Credit Cards in Circulation >FLD

12 maj 2026, 20:34 UTC

Earnings

Fold Holdings: Transaction Volumes Dn 32% YoY >FLD

12 maj 2026, 20:34 UTC

Earnings

Fold Holdings: Restructuring Fees on Bitcoin Gift Card to Drive Distribution >FLD

12 maj 2026, 17:25 UTC

Earnings

EToro Reports Sharp Drop in Crypto Trading. The Stock Falls. -- Barrons.com

12 maj 2026, 14:07 UTC

Major Market Movers

Coincheck Shares Rise on $65M KDDI Investment, Digital-Asset Alliance

12 maj 2026, 13:53 UTC

Market Talk

Bitcoin Seen Primed to Move Higher Following CPI Report -- Market Talk

12 maj 2026, 13:38 UTC

Market Talk

'Altcoin Season' Talk Premature, Says Coinbase -- Market Talk

12 maj 2026, 13:35 UTC

Market Talk

Bitcoin Stays Above $80k in Wider Crypto Pullback -- Market Talk

12 maj 2026, 11:42 UTC

Market Talk

Bitcoin Stays Under Pressure Amid U.S.-Iran Stalemate -- Market Talk

12 maj 2026, 11:41 UTC

Earnings

EToro Reports Sharp Drop in Crypto Trading. Why the Stock Is Rising. -- Barrons.com

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

80.87% upside

12 Months Forecast

Average 14.94 USD 80.87%

High 25 USD

Low 11 USD

Based on 12 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to NeoGenomics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.